REFACTO

UNIVADIS - REFACTO /univadis/REFACTO.md

ATC

Μορφές: PS.INJ.SOL

Ημερομηνία	barcode	code	περιεχομενο	τιμή παραγωγός	χονδρική	λιανική
05/2018	2802408802013	240880201	REFACTO AF PS.INJ.SOL 500 IU/VIAL BTx1VIAL+1PF.SYRx 4ML SOLV+ σετ χορήγησης 4ML SOLV+ σετ χορήγησης	305.05	309.63	361.03
05/2018	2802408803010	240880301	REFACTO AF PS.INJ.SOL 1000 IU/VIAL BTx1 VIAL +1 PF.SYRx 4ML SOLV+ σετ χορήγησης 4ML SOLV+ σετ χορήγησης	610.09	619.26	702.37
05/2018	2802408804017	240880401	REFACTO AF PS.INJ.SOL 2000 IU/VIAL BTx1 VIAL+ 1PF.SYR x4ML SOLV + σετ χορήγησης x4ML SOLV + σετ χορήγησης	1191.54	1209.44	1346.10

DRUGBANK - Antihemophilic Factor
indication:
For the treatment of hemophilia A, von Willebrand diseae and Factor XIII deficiency
pharmacology:
mechanism:
Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).
toxicity:
absorprion:
halflife:
8.4-19.3 hrs
roouteelimination:
volumedistribution:
clearance:
* 4.1 mL/h•kg [Previously treated pediatric patients]